1. Home
  2. NKTR vs BCBP Comparison

NKTR vs BCBP Comparison

Compare NKTR & BCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • BCBP
  • Stock Information
  • Founded
  • NKTR 1990
  • BCBP 2000
  • Country
  • NKTR United States
  • BCBP United States
  • Employees
  • NKTR N/A
  • BCBP N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • BCBP Savings Institutions
  • Sector
  • NKTR Health Care
  • BCBP Finance
  • Exchange
  • NKTR Nasdaq
  • BCBP Nasdaq
  • Market Cap
  • NKTR 160.4M
  • BCBP 170.1M
  • IPO Year
  • NKTR 1994
  • BCBP N/A
  • Fundamental
  • Price
  • NKTR $0.59
  • BCBP $8.30
  • Analyst Decision
  • NKTR Strong Buy
  • BCBP Hold
  • Analyst Count
  • NKTR 6
  • BCBP 2
  • Target Price
  • NKTR $4.92
  • BCBP $11.75
  • AVG Volume (30 Days)
  • NKTR 2.3M
  • BCBP 81.0K
  • Earning Date
  • NKTR 05-08-2025
  • BCBP 04-22-2025
  • Dividend Yield
  • NKTR N/A
  • BCBP 7.71%
  • EPS Growth
  • NKTR N/A
  • BCBP N/A
  • EPS
  • NKTR N/A
  • BCBP 0.15
  • Revenue
  • NKTR $87,248,000.00
  • BCBP $63,178,000.00
  • Revenue This Year
  • NKTR N/A
  • BCBP $25.21
  • Revenue Next Year
  • NKTR N/A
  • BCBP $10.27
  • P/E Ratio
  • NKTR N/A
  • BCBP $55.44
  • Revenue Growth
  • NKTR N/A
  • BCBP N/A
  • 52 Week Low
  • NKTR $0.43
  • BCBP $8.05
  • 52 Week High
  • NKTR $1.93
  • BCBP $14.04
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 39.04
  • BCBP 36.70
  • Support Level
  • NKTR $0.57
  • BCBP $8.11
  • Resistance Level
  • NKTR $0.81
  • BCBP $8.48
  • Average True Range (ATR)
  • NKTR 0.06
  • BCBP 0.31
  • MACD
  • NKTR -0.01
  • BCBP 0.01
  • Stochastic Oscillator
  • NKTR 7.48
  • BCBP 21.55

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

Share on Social Networks: